WallStreetZenWallStreetZen
Analyst Ranking
Top 3%
#100 out of 4484 analysts
Average Return
+13.88%
Win Rate
46%125 out of 273
Risk vs Reward
Poor
Good

Ed Arce's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Vera Therapeutics IncVERA
+549.14%$7.57$49.14
2023-05-12 -
2024-03-01
Buy
Cymabay Therapeutics IncCBAY
+481.01%$1.79$10.40
2022-05-16 -
2023-05-15
Buy
Vera Therapeutics IncVERA
+464.83%$8.70$49.14
2023-06-08 -
2024-03-01
Buy
Viking Therapeutics IncVKTX
+350.00%$2.74$12.33
2017-11-10 -
2018-11-09
Buy
89bio IncETNB
+338.51%$3.48$15.26
2022-07-28 -
2023-07-27
Buy

Ed Arce Analyst Color

Get additional color on Ed Arce's coverage of popular stocks

Ed Arce's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Aurinia Pharmaceuticals IncAUPH
11Buy$13.00+124.91%Reiterates
2 days ago
Akero Therapeutics IncAKRO
13Buy$43.00+54.62%Maintains
2 days ago
Arbutus Biopharma CorpABUS
13Buy$5.00+79.21%Maintains
2 days ago
89bio IncETNB
12Buy$31.00+145.64%Maintains
2 days ago
Mirum Pharmaceuticals IncMIRM
19Buy$45.00+53.74%Maintains
3 days ago
Zyversa Therapeutics IncZVSA
2Buy$24.00+2,207.69%Reiterates
3 days ago
Cymabay Therapeutics IncCBAY
13Hold$32.50+0.84%Reiterates
3 days ago
Acurx Pharmaceuticals IncACXP
9Buy$14.00+372.97%Reiterates
4 days ago
Pliant Therapeutics IncPLRX
13Buy$48.00+190.21%Reiterates
4 days ago
Iterum Therapeutics PLCITRM
3Buy$6.00+361.54%Upgrades
25 days ago
Talphera IncTLPH
8Buy$6.00+358.02%Maintains
a month ago
Terns Pharmaceuticals IncTERN
6Hold$5.50-24.76%Maintains
2 months ago
Vera Therapeutics IncVERA
7Buy$25.00-49.12%Reiterates
2 months ago
Inventiva SaIVA
8Buy$24.00+493.77%Maintains
2 months ago
Unicycive Therapeutics IncUNCY
10Buy$4.50+181.25%Reiterates
2 months ago
Travere Therapeutics IncTVTX
13Buy$20.00+154.13%Maintains
3 months ago
Genfit SaGNFT
9Buy$11.00+203.87%Reiterates
3 months ago
Cidara Therapeutics IncCDTX
15Buy$6.00+742.70%Reiterates
3 months ago
Arcturus Therapeutics Holdings IncARCT
16Buy$51.00+28.37%Reiterates
3 months ago
Enanta Pharmaceuticals IncENTA
6Buy$28.00+82.41%Maintains
3 months ago
Akebia Therapeutics IncAKBA
18Buy$5.00+192.40%Maintains
4 months ago
Madrigal Pharmaceuticals IncMDGL
9Buy$275.00+9.29%Maintains
4 months ago
Ardelyx IncARDX
3Buy$11.00+17.77%Maintains
4 months ago
Intercept Pharmaceuticals IncICPT
10Hold$19.000.00%Downgrades
5 months ago
Galectin Therapeutics IncGALT
6Buy$11.00+469.95%Reiterates
7 months ago
Synlogic IncSYBX
6Buy$75.00+3,932.26%Reiterates
7 months ago
Durect CorpDRRX
6Buy$27.00+2,652.29%Maintains
7 months ago
Paratek Pharmaceuticals IncPRTK
9Hold$2.15-3.59%Reiterates
7 months ago
Ultragenyx Pharmaceutical IncRARE
2Buy$82.00+52.73%Reiterates
7 months ago
Chinook Therapeutics IncKDNY
3Hold$40.00-0.97%Reiterates
8 months ago
Assembly Biosciences IncASMB
2Hold$18.00+33.63%Maintains
a year ago
Albireo Pharma IncALBO
7Hold$42.00N/AReiterates
a year ago
Axcella Health IncAXLA
4HoldN/AN/ADowngrades
a year ago
Mimecast LtdMIME
1Buy$69.00N/AMaintains
2 years ago
Entasis Therapeutics Holdings IncETTX
3Hold$1.80N/ADowngrades
2 years ago
Dicerna Pharmaceuticals IncDRNA
6Hold$38.25N/ADowngrades
2 years ago
Metacrine IncMTCR
2HoldN/AN/ADowngrades
2 years ago
Galmed Pharmaceuticals LtdGLMD
3Buy$375.00N/AMaintains
3 years ago
Avenue Therapeutics IncATXI
2Buy$195.00N/AMaintains
4 years ago
Trevena IncTRVN
4Buy$87.50N/AAssumes
5 years ago
Tetraphase Pharmaceuticals IncTTPH
2Buy$7.00N/AMaintains
6 years ago
Viking Therapeutics IncVKTX
1Buy$7.00N/AAssumes
6 years ago
Ocera Therapeutics IncOCRX
1HoldN/AN/ADowngrades
6 years ago
Collegium Pharmaceutical IncCOLL
1Buy$21.00N/AInitiates Coverage On
6 years ago
Nabriva Therapeutics PLCNBRVF
2Buy$4,500.00N/AMaintains
7 years ago
Atea Pharmaceuticals IncAVIR
1HoldN/AN/ADowngrades
7 years ago
Medicines CoMDCO
1Buy$57.00N/AInitiates Coverage On
7 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.